FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080071 [Registered on: 07/02/2025] Trial Registered Prospectively
Last Modified On: 04/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A randomised study to study the impact of Pancreaticodudoenectomy done using ePTFE on pancreatic fistula  
Scientific Title of Study   Impact of ePTFE Suture for Pancreaticojejunosotmy on Clinically Relevant Post-operative Pancreatic Fistula after Pancreatoduodenectomy: A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pavithran T 
Designation  Senior Resident 
Affiliation  All India Institute of Medical Sciences, Jodhpur 
Address  Department of Surgical Gastroenterology, All India Institute of Medical Sciences Basni Industrial Area, Phase 2, Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  9944280086  
Fax    
Email  pavithrant11@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Peeyush Varshney 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Sciences, Jodhpur 
Address  Department of Surgical Gastroenterology, All India Institute of Medical Sciences Basni Industrial Area, Phase 2, Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  9929069007  
Fax    
Email  drpeeyushvarshney@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Peeyush Varshney 
Designation  Associate Professor 
Affiliation  All India Institute of Medical Sciences, Jodhpur 
Address  Department of Surgical Gastroenterology, All India Institute of Medical Sciences Basni Industrial Area, Phase 2, Jodhpur

Jodhpur
RAJASTHAN
342005
India 
Phone  9929069007  
Fax    
Email  drpeeyushvarshney@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Medical Sciences , Jodhpur 
 
Primary Sponsor  
Name  Pavithran T 
Address  Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Basni Industrial Area, Phase 2, Jodhpur 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pavithran T  All India Institute Of Medical Sciences, Jodhpur  Department of Surgical Gastroenterology, 5th Floor, C block, Room No.-549 AIIMS, Basni Industrial Area, Phase-II, Jodhpur
Jodhpur
RAJASTHAN 
9944280086

pavithrant11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D132||Benign neoplasm of duodenum, (2) ICD-10 Condition: D136||Benign neoplasm of pancreas, (3) ICD-10 Condition: C240||Malignant neoplasm of extrahepaticbile duct, (4) ICD-10 Condition: C241||Malignant neoplasm of ampulla of Vater, (5) ICD-10 Condition: C253||Malignant neoplasm of pancreatic duct, (6) ICD-10 Condition: C250||Malignant neoplasm of head of pancreas,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard duct-to-mucosa pancreaticojejunostomy  Firstly, the resection part of Pancreatoduodenectomy will be performed as per the inclusion criteria. Following this, a duct-to-mucosa pancreaticojejunostomy will be done using PDS suture in the comparator arm. In the postoperative period, the incidence of clinically relevant pancreatic fistula will be analyzed and compared with the intervention group. 
Intervention  Use of ePTFE for Pancreaticojejunostomy  Firstly, the resection part of Pancreatoduodenectomy will be performed as per the inclusion criteria. Following this, a duct-to-mucosa pancreaticojejunostomy will be done using ePTFE suture in the intervention arm. In the postoperative period, the incidence of clinically relevant pancreatic fistula will be analyzed and compared with the comparator group.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Patients undergoing Pancreatoduodenectomy with
duct-to-mucosa Pancreaticojejunostomy
2. Benign or Malignant
etiologies
3. More than or equal to 18 years of age 
 
ExclusionCriteria 
Details  1. Dunking type of pancreaticojejunostomy
2. Pancreaticogastrostomy
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Development of Clinically Relevant Post
Operative Pancreatic Fistula (type B and C) as
per the ISGPS definition 
1 week 
 
Secondary Outcome  
Outcome  TimePoints 
1. Duration of stay in the intensive care unit (ICU).
2. Duration of post-operative hospital stay.
3. Reintervention
4. 30-day morbidity
a. Deep/organ space infection
b. Delayed gastric emptying.
c. Post-pancreatomy hemorrhage.
d. Other complications
5. 90 day Mortality
 
3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   15/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Although different surgical approaches are currently used for PD (Pancreatoduodenectomy), there does not seem to be an optimal technique that significantly decreases POPF rates [1]. Despite postoperative mortality rates having significantly decreased to less than 5%, PD may still be associated with relevant morbidity, mainly related to POPF (Post-Operative Panceatic Fistula) (2,3). Various studies have evaluated the role of application of sealant patches in prevention of POPF after pancreaticoojejunostomy . However only few studies  study till date has evaluated the efficacy of e PTFE sutures in preventing CR-POPF (Clinically-Relevant Post-Operative Panceatic Fistula) after pancreatoduodenectomy in the Indian scenario 
Close